Emmaus Life Sciences Inc (EMMA)
0.10
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Emmaus Life Sciences Revenue (TTM): 28.46M for Sept. 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 28.46M |
| June 30, 2023 | 28.38M |
| March 31, 2023 | 21.91M |
| December 31, 2022 | 18.39M |
| September 30, 2022 | 15.48M |
| June 30, 2022 | 16.31M |
| March 31, 2022 | 18.51M |
| December 31, 2021 | 20.61M |
| September 30, 2021 | 23.84M |
| June 30, 2021 | 23.68M |
| March 31, 2021 | 21.55M |
| December 31, 2020 | 23.17M |
| September 30, 2020 | 22.41M |
| June 30, 2020 | 22.89M |
| March 31, 2020 | 19.06M |
| December 31, 2019 | 12.56M |
| September 30, 2019 | 7.458M |
| June 30, 2019 | 1.716M |
| March 31, 2019 | 1.581M |
| December 31, 2018 | 1.581M |
| September 30, 2018 | 1.316M |
| June 30, 2018 | 1.008M |
| March 31, 2018 | 0.6563M |
| December 31, 2017 | 0.2283M |
| September 30, 2017 | 0.1285M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.1131M |
| March 31, 2017 | 0.0938M |
| December 31, 2016 | 0.0826M |
| September 30, 2016 | 0.0851M |
| June 30, 2016 | 0.092M |
| March 31, 2016 | 0.1019M |
| December 31, 2015 | 0.1021M |
| September 30, 2015 | 0.1001M |
| June 30, 2015 | 0.0993M |
| March 31, 2015 | 0.0944M |
| December 31, 2014 | 0.1128M |
| September 30, 2014 | 0.1351M |
| June 30, 2014 | 0.158M |
| March 31, 2014 | 0.1578M |
| December 31, 2013 | 0.1477M |
| September 30, 2013 | 0.1309M |
| June 30, 2013 | 0.1083M |
| March 31, 2013 | 0.1152M |
| December 31, 2012 | 0.1112M |
| September 30, 2012 | 0.115M |
| June 30, 2012 | -0.336M |
| March 31, 2012 | -0.171M |
| December 31, 2011 | -0.0044M |
| September 30, 2011 | 0.1115M |
| June 30, 2011 | 0.695M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.716M
Minimum
Jun 2019
28.46M
Maximum
Sep 2023
19.24M
Average
21.08M
Median
Revenue (TTM) Benchmarks
| AIM ImmunoTech Inc | 0.202M |
| Perspective Therapeutics Inc | 0.00 |
| Protalix BioTherapeutics Inc | 65.49M |
| Electromed Inc | 51.69M |
| Armata Pharmaceuticals Inc | -- |